USPTO Deadlines
Next Deadline
1526 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20100406)
Due Date
April 06, 2030
Grace Period Ends
October 06, 2030
Application History
50 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 3, 2019 | NA89 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | Loading... |
| Jun 3, 2019 | RNL1 | Q | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | Loading... |
| Jun 3, 2019 | 89AG | O | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | Loading... |
| Jun 3, 2019 | EROP | I | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | Loading... |
| May 17, 2019 | PR89 | O | POST REGISTRATION ACTION MAILED - SEC. 8 & 9 | Loading... |
| May 17, 2019 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Apr 24, 2019 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Apr 18, 2019 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Apr 18, 2019 | E89R | I | TEAS SECTION 8 & 9 RECEIVED | Loading... |
| Apr 6, 2019 | REM2 | E | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | Loading... |
| Jan 5, 2017 | NAS8 | E | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | Loading... |
| Jan 5, 2017 | 8.OK | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED | Loading... |
| Jan 5, 2017 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Sep 27, 2016 | ES8R | I | TEAS SECTION 8 RECEIVED | Loading... |
| Sep 27, 2016 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Apr 6, 2010 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Mar 1, 2010 | REGV | O | LAW OFFICE REGISTRATION REVIEW COMPLETED | Loading... |
| Feb 22, 2010 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Feb 22, 2010 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED | Loading... |
| Feb 22, 2010 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 19, 2010 | I | PAPER RECEIVED | Loading... | |
| Oct 27, 2009 | CNRT | O | NON-FINAL ACTION MAILED | Loading... |
| Oct 26, 2009 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN | Loading... |
| Oct 23, 2009 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Oct 6, 2009 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Oct 23, 2009 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Oct 6, 2009 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Apr 28, 2009 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Apr 28, 2009 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Apr 28, 2009 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 11, 2008 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 19, 2008 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 30, 2008 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Jul 17, 2008 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Jul 16, 2008 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jul 14, 2008 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 14, 2008 | CNEA | O | EXAMINERS AMENDMENT MAILED | Loading... |
| Jul 14, 2008 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jul 14, 2008 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jul 10, 2008 | CNFR | O | FINAL REFUSAL MAILED | Loading... |
| Jul 9, 2008 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Jul 2, 2008 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 11, 2008 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED | Loading... |
| Jun 11, 2008 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 10, 2008 | FAXX | I | FAX RECEIVED | Loading... |
| Jan 10, 2008 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
| Jan 10, 2008 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jan 7, 2008 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 24, 2007 | AMPX | O | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | Loading... |
| Nov 21, 2007 | ALIE | A | ASSIGNED TO LIE | Loading... |
Detailed Classifications
Class 005
Full line of bulk pharmaceuticals, pharmaceutical intermediates, pharmaceutical preparations, antibiotics for animals and humans, animal feed supplements, human food supplements, herbal supplements for animals and humans, mineral supplements for animals and humans, dietary supplements for animals and humans, and vitamins for animals and humans in the form of caplets, capsules, creams, drops, douches, foams, gel-tabs, gels, inhalants, injectables, lotions, ointments, pastilles, powders, rinses, shampoos, solutions, spansules, sponges, sprays, suppositories, syrups and tablets; ace-inhibitors; adrenergic agonists; adrenergic blockers; anabolics; analgesics, narcotic and non-narcotic analgesics; anesthetics; antianorexics; antacids; anthelmintics; antiacnes; antiallergics; antianginals; antiarthritics and antirheumatics; antiasthmatics; antibacterials; antibiotics; anticoagulants; anticonvulsants; antidepressants; antidiabetics; antidiarrheals; antidiuretics; antiemetics; antifungals; antiglaucomas; antihistaminics; antihypertensives; antihyperthyroids; antihypotensives; anti-inflammatories; anti-itch creams, ointments and sprays; antimalarials; antimigraines; antimuscarinics; antineoplastics; antioxidants; antiparkinsonians; antiprotozoals; antipruritics; antipsoriatics; antipsychotics; antiseborrheics; antiseptics; antispasmodics; antisyphilitics; antithrombotics; antitussives; antiulceratives; antivirals; anxiolyties; astringents; bacteriostats for medicinal, dental and veterinary use; bath salts for medical purposes; beta-blockers; biocides; biological and chemical reagents for medical or veterinary use; bronchodilators; burn-relief medications; calcium channel blockers; cardiotonics; nutritional additives for use in dietary supplements, namely, carotenoids; chemotherapeutics; choleretics; cholesterol reducers; cholinergics; cholinesterase inhibitors; cleansing solutions for medical use; clinical medical reagents; CNS stimulants; contraceptives; decongestants; dermatologicals; diagnostic preparations for medical purposes; dietary and nutritional supplements; diuretics; dopamine receptor agonists; enzyme cofactors; estrogens; expectorants; food supplements; gastric and pancreatic preparations; germicides; glucosidase inhibitors; gonad-stimulating principles; hematinics; hematopoietics; hemostatics; hepatoprotectants; herbal products, namely, aromatherapy packs containing herbs used for relief from headaches, insomnia and sinus discomfort; homeopathic supplements; immunomodulators; immunosuppressants; laxatives; medicinal herbal extracts; mineral nutritional supplements; mineralocorticoids; mixed vitamin preparations; mucolytics; multi-vitamin preparations; muscle relaxants; mydriatics; neutraceuticals for use as dietary supplements; nootropics; nutritional additives to foodstuffs for animals, for medical purposes; nutritional additives for medical purposes for use in foods and dietary supplements for human consumption; plant extracts for medical, veterinary and pharmaceutical purposes; processed food adapted for medical purposes; progestogens; prolactin inhibitors; prostaglandins and prostaglandin analogs; dietary supplements; respiratory stimulants; reverse transcriptase inhibitors; sedatives; seratonin receptor agonists and antagonists; soy protein for use as a nutritional ingredient in various powdered and ready-to-drink beverages; medicated topical skin protectants for medical use; vasodilators; vasoprotectants; vitamin and mineral preparations for use as ingredients in the food and pharmaceutical industry; yeast or yeast extracts for medical, veterinary or pharmaceutical purposes
First Use Anywhere:
Jun 17, 2009
First Use in Commerce:
Jun 17, 2009
Additional Information
Design Mark
The mark consists of a triangle having an upper part and a lower part. The upper part is a light blue field surrounding a white triangle and the lower part is a dark blue field surrounding two white triangles.
Color Claim
The color(s) light blue, dark blue and white is/are claimed as a feature of the mark.
Classification
International Classes
005